DOTTIKON ES HOLDING AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 258.8 CHF | -0.48% |
|
-1.34% | +12.88% |
| May. 29 | Dottikon ES Holding AG Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| May. 28 | Dottikon ES Posts Lower FY24 Net Income; Net Sales Up | MT |
| Sales 2025 * | - | Sales 2026 * | - | Capitalization | 3.58B 3.19B |
|---|---|---|---|---|---|
| Net income 2025 * | - | Net income 2026 * | - | EV / Sales 2025 * | - |
| Net cash position 2025 * | - 0 | Net cash position 2026 * | - 0 | EV / Sales 2026 * | - |
| P/E ratio 2025 * |
51.2
x | P/E ratio 2026 * |
-
| Employees | 678 |
| Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 27.87% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -0.95% | ||
| 1 week | -1.89% | ||
| Current month | -0.76% | ||
| 1 month | +5.26% | ||
| 3 months | +9.94% | ||
| 6 months | +23.22% | ||
| Current year | +13.54% |
1 week
258.00
267.00
1 month
248.50270.00
Current year
208.50270.00
1 year
190.40270.00
3 years
186.00370.00
5 years
44.00370.00
10 years
18.51370.00
| Managers | Title | Age | Since |
|---|---|---|---|
Markus Blocher
CEO | Chief Executive Officer | 53 | 02-12-31 |
Marlene Born
DFI | Director of Finance/CFO | 49 | 04-12-31 |
Urs Brändli
CTO | Chief Tech/Sci/R&D Officer | 64 | 89-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Markus Blocher
CEO | Chief Executive Officer | 53 | 02-12-31 |
| Director/Board Member | 67 | 11-06-30 | |
Bernhard Urwyler
BRD | Director/Board Member | 66 | 20-07-02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 746 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +4.23% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 258.5 | -0.58% | 719 |
| 24-06-06 | 260 | -0.95% | 1,133 |
| 24-06-05 | 262.5 | +0.96% | 2,159 |
| 24-06-04 | 260 | 0.00% | 8,401 |
| 24-06-03 | 260 | -0.76% | 4,623 |
Delayed Quote Swiss Exchange, June 06, 2024 at 11:31 am EDT
More quotes
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
Sector
Pharmaceuticals
Calendar
2024-07-04
- Annual General Meeting
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
260
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +13.54% | 4.02B | |
| +43.64% | 754B | |
| +39.42% | 630B | |
| -6.58% | 352B | |
| +19.72% | 331B | |
| +8.78% | 298B | |
| +11.92% | 217B | |
| -2.62% | 216B | |
| +0.03% | 163B | |
| +6.13% | 164B |
- Stock Market
- Equities
- DESN Stock
